Health · Obesity
FDA Approves First Daily Pill for Obesity, a Pill Form of Wegovy
Novo Nordisk expects the 25-milligram semaglutide tablet to be available within weeks; rival Eli Lilly’s oral drug is still under review.
Edition of Monday, December 22, 2025
The day's stories as a front page. All editions